HbA1c Medicare reimbursement is now available

 
 
 

cobas b 101 offers HbA1c diagnosis

and monitoring at the Point of Care


Improving the outcomes for patients living with diabetes

 
 

Register for our upcoming AGPAL webinar series

Learn how to leverage HbA1c diagnosis and monitoring at the Point of Care to significantly improve the outcomes for your patients living with diabetes, and how to prepare your practice for the upcoming rebate. 


You will also receive Continuing Professional Development (CPD) points for RACGP, AAPM and APNA for your attendance, as well as an electronic certificate of attendance for CPD recognition.


Unable to make an upcoming webinar or missed a previous one? All webinars are recorded!
Please register your interest below to receive more information.

 

Benefits for your patients

Combined Testing

The cobas b 101 system includes tests for glycated haemoglobin (HbA1c), lipid panel and C-reactive protein (CRP) on the same device.

 

 

Fast turnaround time

HbA1c result in 5 mins. On the spot results in just 3 simple steps. Dual testing from one finger prick sample allows for HbA1c test and lipid panel within a 15-minute workflow cycle.

Better patient compliance

Compared with laboratory testing, POC HbA1c testing has been shown to significantly increase the proportion of patients achieving their diabetes glycaemic control.1

 

Simple and easy sample collection

Direct blood sample application onto disc from a finger prick, with no need for tubes or pipettes for sample collection or transfer. Test discs can be conveniently stored at room temperature (2-30ºc).

 
 

3 tests in one a compact portable system

HbA1c Test

 

HbA1c (glycated haemoglobin) testing improves diabetes management in primary care settings

  • HbA1c with Diagnosis Claim 2
  • No interference from most common haemoglobin variants2
  • Precision is fully compliant with the IFCC and NGSP guideline requirements3
  • Requires 2 μL drop of capillary or venous whole blood. HbA1c test results in 5 mins
  • HbA1c result displayed in percentage (%) plus mmol/mol

Lipid Panel Test

 

Closing the gap in cardiovascular (CV) risk factor management

  • Precision is fully compliant with the NCEP guideline requirements 4
  • Requires 19 μL drop of capillary or venous whole blood or plasma
  • Lipid test results in 6 mins; including TC, HDL, TG, LDL, non-HDL and TC/HDL ratio

 

CRP Test

 

C-reactive protein (CRP) test supports appropriate antibiotic use at the Point of Care

  • POC CRP testing follows the recommendations of the NICE clinical guidance5
  • Requires 12 μL drop of capillary blood or serum, venous whole blood or plasma.
  • CRP results in 4 mins
  • CRP results displayed in mg/L

To download our brochure and flyer or speak to our specialist, contact Roche Diagnostics Australia.

cobas b 101

Overview


View how to perform a HbA1c test

on the cobas b 101 system.

 

3 simple steps

to better patient outcomes

Power on the instrument and touch Patient Test.

Open the lid, lance the finger and place the drop of blood on the test disc.

Place test disc in the cobas b 101 and close lid. The measurement starts automatically.

Benefits of cobas b 101 system

Easy and intuitive to use

Colour touch screen with a user-friendly interface that has the same look and feel as other Roche Point of Care devices.

Improves workflow efficiency

 

Patient data storage with 5,000 patient results, 500 QC results, and 50 Operator IDs.

Compact and Portable

Lightweight and portable. Weighs 2kg, with a small footprint.

 

Automatic calibration on each disc

Samples and discs are checked for integrity and all steps of the process are controlled. No service required.

Guaranteed with a 3 Year Warranty.

Roche Point-of-Care Solutions
for on the spot decisions

 

From the makers of CoaguChek®

 

Roche offers you a broad variety of PoCT systems with more than 15 parameters, which allows you to support your patients with rapid results for their general and major health concerns.

 

The accurate results correlate well to the specific laboratory methods and provide peace of mind for you and your patients.6-14

 

Our proven systems and comprehensive services make testing in your own office/institution reliable, easy and efficient – with only one point of contact.


Contact us to register your interest in the upcoming AGPAL webinar series

or to find out more about how to get your practice ready for the Hba1c rebate

DISCLAIMER. This website contains information on products that are targeted to a wide range of audiences. Please be aware that Roche Diagnostics Australia Pty Limited does not take any responsibility for accessing that information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Please also be aware that the information on this website should not be used to diagnose, treat, cure or prevent any disease without the advice of a qualified medical professional, and does not replace medical advice or a medical examination.

 

Visit Roche Diagnostics Australia ›

 

Roche Diagnostics Australia Pty Limited
ABN 29 003 001 205
2 Julius Avenue
North Ryde NSW 2113 Australia
Phone: 02 9860 2222

COBAS, COBAS B and COAGUCHEK are trademarks of Roche. © 2022 Roche Diagnostics

 

Reference: 1. Bubner, T.K., Laurence, C.O., Gialamas, A., Yelland, L.N., Ryan, P., Willson, K.J. et al. (2009). Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results from the PoCT in General Practice Trial. Med JAust 1 90, 624–6262. 2. Roche cobas b 101 Test Package Inserts. 3. www.ifcc.org (accessed Feb 2013) 4. NIH; NCEP Third Report, The National Heart, Lung and Blood Institute. 5. NICE clinical guidance [CG101] (2014). Available at: www.nice.org.uk/guidance/CG101 6. Roche (2013). Multicenter evaluation of the cobas b 101 system for the measurement of HbA1c and lipid panel 7. Roche (2018). Multicenter evaluation of the cobas CRP Test on the cobas b 101 POC system 8. Roche 2009. Accutrend Plus evaluation folder: The simple way to screen for cardiovascular disease risk factors. 2009. 9. Nagel D et al. Investigations of ascorbic acid interference in urine test strips. Clin Lab. 2006. 52 (3-4): 149-153. 10. Dempfle, CE et al. on behalf of the CARDIM study group. Sensitivity and specificity of a quantitative PoCT Ddimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis. Tromb Haemost 2006. 95: 79-83. 11. Derhaschnig, U et al. Diagnostic efficiency of a point-of- care system for quantitative determination of troponin T and myoglobin in the coronary care unit. PoCT 2004. 3(4): 162-164. 12. Schäfer, M et al. on behalf of the CARPRO Multicentre Study Group. Diagnostic equivalence of an NT-proBNP point-of-care test to the laboratory method in patients with heart failure and in reference populations. Point of Care: The Journal of Near-Patient Testing and Technology June 2010 - Volume 9 - Issue 2 - pp 91-97 13. Bertsch, T et al. on behalf of the cobas h 232 evaluators. Multicentre evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers (in preparation). Journal of Clin Lab. 2010:56(1-2):37-49 14. Plesch W et al. Results of the performance verification of the CoaguChek XS system. Tromb Res 2008. 123: 381-389.